BEIJING, April 10, 2026 -- The global medical device industry is entering a pivotal period of high-quality development in 2026, driven by technological innovation, policy support and rising global healthcare demand, with AI-enabled devices, surgical robots and remote monitoring equipment leading the market growth, while facing challenges such as regulatory scrutiny and core component shortages, according to the latest industry reports and trade statistics.
The global medical device market is showing strong growth momentum. Data from 360 Research Reports indicates that the global market size is expected to reach USD 670.39 billion in 2026 and is projected to grow at a compound annual growth rate (CAGR) of 5.2% from 2026 to 2035, eventually reaching nearly USD 1.05 trillion by 2035. This growth is mainly fueled by the expansion of healthcare systems worldwide, the upgrading of aging medical infrastructure, and the increasing adoption of digital and automated medical devices, with 54% of new installations in 2026 involving digital or automated systems.
China, a major player in the global medical device market, has achieved remarkable growth in exports at the beginning of 2026. Customs data compiled by the China Chamber of Commerce for Import and Export of Medicines and Health Products shows that from January to February 2026, China's medical device imports and exports reached USD 12.86 billion, accounting for 41.6% of the total import and export volume of medical products. Among them, exports surged by 17.64% year-on-year to USD 8.67 billion, with hospital diagnosis and treatment equipment leading the growth with a 19.22% year-on-year increase in exports, while imports fell by 13.47% year-on-year, reflecting the continuous improvement of domestic enterprises' independent substitution capacity in the mid-to-high-end sector.
Technological innovation has become the core driving force of the industry's development, with AI integration and intelligent devices becoming mainstream trends. IDC data shows that China's AI medical market size is expected to exceed USD 42 billion in 2026, a year-on-year increase of 88%, with AI functions such as lung nodule recognition and stroke early warning having become standard configurations for medical imaging systems. Surgical robots are also entering a commercial inflection point: 52 surgical robots were approved in China in 2025, with orthopedic robots accounting for 23, and domestic brands such as MicroPort and Jifeng have achieved technological parity with international counterparts, driving the popularization of minimally invasive surgeries in primary medical institutions.
Policy support has further boosted the development of the industry. In 2026, China launched the second phase of medical infrastructure construction, with over USD 93.6 billion in ultra-long-term special bonds allocated to support medical device updates, driving a total investment of more than USD 460 billion. The National Health Commission has also clarified that it will invest over USD 80 billion in the next two years to support equipment updates and informatization construction in 1,400 county-level hospitals, with "domestic priority" included in procurement standards. Meanwhile, the review cycle for innovative medical devices has been shortened to within 6 months, accelerating the market launch of clinically needed products.
However, the industry still faces multiple challenges. A January 2026 survey by Medical Economics shows that regulatory pressure, supply chain vulnerabilities and industry consolidation have become major obstacles for enterprises. Core components such as precision robotic arms and medical imaging chips remain highly dependent on imports, with an import ratio exceeding 70%, squeezing the profit space of domestic enterprises. In addition, 42% of global medical institutions identified high equipment costs as the main factor affecting purchase decisions, while small and medium-sized enterprises are also facing pressure from rising compliance costs and prolonged hospital payment cycles.
Regional market performance shows obvious differentiation. North America remains the largest consumer market, accounting for 36% of global medical device consumption, with the United States alone having more than 980,000 active medical devices in use. Emerging markets in Asia, Africa and Latin America are showing rapid growth potential, driven by the expansion of local healthcare infrastructure. Industry analysts predict that in 2026, the global medical device industry will focus on four key trends: AI-enabled devices, minimally invasive technologies, wearable monitoring equipment and sustainable manufacturing, and enterprises that focus on core technology R&D and global layout will gain greater competitive advantages.
In addition, the global push for reshoring and regionalization of medical device manufacturing is gaining momentum, as enterprises seek to enhance supply chain resilience. However, this shift also brings challenges such as higher labor costs and capital investment demands, further intensifying market competition among global manufacturers.